Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q3 2024 13F
2,817,763
2,938,754
+4.3%
Share count drives classification; reported value also moves with price
0.20%
Within the filing's reported positions, not the manager's total assets
1
For Q4 2024
Fund moves
From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Insider buying
Traded Dec 4, 2024 · filed 2 days later
A Perspective Therapeutics director paid $100K out of pocket for Perspective Therapeutics shares. 3 other people at Perspective Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Dec 4, 2024 · filed the same day
The CEO of Perspective Therapeutics paid $30K out of pocket for Perspective Therapeutics shares. 3 other people at Perspective Therapeutics bought some too, in the same month. Shares held went up 28% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
